The neuroscience market size has grown strongly in recent years. It will grow from $37.47 billion in 2025 to $40.35 billion in 2026 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to advancements in cellular imaging technologies, increased neuroscience research funding, early development of electrophysiology systems, rising neurological disease prevalence, adoption of brain imaging techniques.
The neuroscience market size is expected to see strong growth in the next few years. It will grow to $54.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growing demand for advanced microscopy systems, increasing integration of ai in neuroscience research, expanding applications of neuroinformatics, rising adoption of brain-mapping tools, development of next-generation electrophysiology devices. Major trends in the forecast period include rising adoption of neuro-microscopy platforms, increasing use of electrophysiology technologies, growth in neuro-cellular manipulation techniques, expansion of whole brain imaging applications, advancements in neuroscience research tools & instruments.
Increased incidences of neurological disorders, including Alzheimer’s disease, are expected to drive the growth of the neuroscience market. Neurological disorders encompass a wide range of medical conditions that primarily impact the nervous system, including the brain, spinal cord, and peripheral nerves. Alzheimer’s disease is a progressive neurodegenerative condition that mainly affects the brain, resulting in a gradual decline in cognitive abilities and memory. Neuroscience plays a crucial role in understanding and managing Alzheimer’s disease (AD). By examining the structure and functions of the nervous system, neuroscientists are gaining valuable insights into the causes of AD and are developing new approaches for its diagnosis, prevention, and treatment. For instance, in May 2024, according to a report by the Alzheimer’s Association, a U.S.-based nonprofit organization focused on Alzheimer’s care, support, and research, the number of Americans aged 65 and above living with Alzheimer’s dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Therefore, the rising incidence of neurological disorders such as Alzheimer’s disease is fueling the neuroscience market.
Major companies operating in the neuroscience market are focusing on the development of innovative technologies, including artificial intelligence and machine learning, to advance neuroscience research and applications. Artificial intelligence allows machines to replicate and, in some cases, surpass human cognitive capabilities, while machine learning is a subset of artificial intelligence. AI-based models are designed to perform intelligence-driven tasks, offering new insights into how similar processes are regulated within the human brain. For example, in February 2024, Koninklijke Philips N.V., a Netherlands-based technology company, in collaboration with Synthetic MR, a Sweden-based MRI software company, introduced Smart Quant Neuro 3D, an advanced solution for diagnosing and evaluating brain disorders such as multiple sclerosis, traumatic brain injury, and dementia. This solution combines Philips’ AI-powered SmartSpeed technology, the 3D SyntAc application, and Synthetic MR’s SyMRI NEURO 3D software, enabling healthcare providers to achieve improved diagnostic accuracy, greater confidence, and better patient outcomes. Philips holds exclusive rights to offer SyMRI NEURO 3D on its MR systems.
In August 2024, AbbVie Inc., a U.S.-based biopharmaceutical company, finalized the acquisition of Cerevel Therapeutics for approximately US$ 8.7 billion. Through this acquisition, AbbVie seeks to substantially strengthen its neuroscience pipeline by obtaining access to Cerevel’s clinical-stage and preclinical assets focused on psychiatric and neurological conditions, including schizophrenia, Parkinson’s disease, mood disorders, and epilepsy. Cerevel Therapeutics is a U.S.-based company with a robust pipeline of potential first-in-class and best-in-class neuropsychiatric therapies.
Major companies operating in the neuroscience market are Alpha Omega Inc., General Electric Company, Siemens Healthineers AG, NeuroNexus Technologies Inc., Doric Lenses Inc., Blackrock Neurotech, Axion Biosystems Inc., Femtonics Ltd., Carl Zeiss AG, Danaher Corporation (Leica Microsystems), Koninklijke Philips N.V., Toshiba Corporation, Hitachi Medical Corporation, Scientifica Ltd., Intan Technologies Inc., Laserglow Technologies Inc., Mightex Systems, Neuralink Corporation, Kernel Corporation, BrainCo Inc., MindMaze Inc., Paradromics Inc., NeuroPro Inc., NeuroSky Inc., EMOTIV Inc., Cercare Medical A/S, Plexon Inc., Noldus Information Technology bv, Neuralynx Inc., Vigil Neuroscience.
North America was the largest region in the neuroscience market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroscience market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neuroscience market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neuroscience market by increasing the cost of importing advanced imaging components, electrophysiology equipment, and laboratory-grade optical systems essential for research and diagnostics. These cost pressures are most significant in regions dependent on imported scientific instruments, particularly Europe and Asia-Pacific, causing delays in the availability of neuro-microscopy, whole brain imaging systems, and electrophysiology devices. Segments such as research institutes, diagnostic labs, and hospitals face higher procurement expenses and extended installation timelines. Despite the challenges, tariffs are encouraging localized manufacturing, stimulating regional innovation, and supporting domestic suppliers of laboratory equipment.
The neuroscience market research report is one of a series of new reports that provides neuroscience market statistics, including neuroscience industry global market size, regional shares, competitors with a neuroscience market share, detailed neuroscience market segments, market trends and opportunities, and any further data you may need to thrive in the neuroscience industry. This neuroscience market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neuroscience is the field that focuses on the study of the human brain and nervous system, utilizing cellular and molecular biology, anatomy and physiology, human behavior and cognition, and related disciplines to mechanistically map brain function. Neuroscience supports the development of drugs as well as treatment and prevention approaches for neurological conditions and also contributes to addressing a wide range of other health issues.
The primary types of neurosciences include neuro-microscopy, electrophysiology technologies, neuro-cellular manipulation, whole brain imaging, and others, which are delivered through instruments, consumables, and software and services. Neuro-microscopy refers to a specialized operating microscope designed for procedures involving the brain, spinal cord, and spine. It is used to illuminate and magnify deeper areas of the surgical field and features a binocular head with adjustable eyepieces and foot controls that enable unrestricted arm movement. Neuroscience applications are utilized by hospitals, diagnostic laboratories, and research and academic institutions.
The neuroscience market consists of the revenues earned by consulting services, installation services, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The neuroscience market size is expected to see strong growth in the next few years. It will grow to $54.01 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to growing demand for advanced microscopy systems, increasing integration of ai in neuroscience research, expanding applications of neuroinformatics, rising adoption of brain-mapping tools, development of next-generation electrophysiology devices. Major trends in the forecast period include rising adoption of neuro-microscopy platforms, increasing use of electrophysiology technologies, growth in neuro-cellular manipulation techniques, expansion of whole brain imaging applications, advancements in neuroscience research tools & instruments.
Increased incidences of neurological disorders, including Alzheimer’s disease, are expected to drive the growth of the neuroscience market. Neurological disorders encompass a wide range of medical conditions that primarily impact the nervous system, including the brain, spinal cord, and peripheral nerves. Alzheimer’s disease is a progressive neurodegenerative condition that mainly affects the brain, resulting in a gradual decline in cognitive abilities and memory. Neuroscience plays a crucial role in understanding and managing Alzheimer’s disease (AD). By examining the structure and functions of the nervous system, neuroscientists are gaining valuable insights into the causes of AD and are developing new approaches for its diagnosis, prevention, and treatment. For instance, in May 2024, according to a report by the Alzheimer’s Association, a U.S.-based nonprofit organization focused on Alzheimer’s care, support, and research, the number of Americans aged 65 and above living with Alzheimer’s dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Therefore, the rising incidence of neurological disorders such as Alzheimer’s disease is fueling the neuroscience market.
Major companies operating in the neuroscience market are focusing on the development of innovative technologies, including artificial intelligence and machine learning, to advance neuroscience research and applications. Artificial intelligence allows machines to replicate and, in some cases, surpass human cognitive capabilities, while machine learning is a subset of artificial intelligence. AI-based models are designed to perform intelligence-driven tasks, offering new insights into how similar processes are regulated within the human brain. For example, in February 2024, Koninklijke Philips N.V., a Netherlands-based technology company, in collaboration with Synthetic MR, a Sweden-based MRI software company, introduced Smart Quant Neuro 3D, an advanced solution for diagnosing and evaluating brain disorders such as multiple sclerosis, traumatic brain injury, and dementia. This solution combines Philips’ AI-powered SmartSpeed technology, the 3D SyntAc application, and Synthetic MR’s SyMRI NEURO 3D software, enabling healthcare providers to achieve improved diagnostic accuracy, greater confidence, and better patient outcomes. Philips holds exclusive rights to offer SyMRI NEURO 3D on its MR systems.
In August 2024, AbbVie Inc., a U.S.-based biopharmaceutical company, finalized the acquisition of Cerevel Therapeutics for approximately US$ 8.7 billion. Through this acquisition, AbbVie seeks to substantially strengthen its neuroscience pipeline by obtaining access to Cerevel’s clinical-stage and preclinical assets focused on psychiatric and neurological conditions, including schizophrenia, Parkinson’s disease, mood disorders, and epilepsy. Cerevel Therapeutics is a U.S.-based company with a robust pipeline of potential first-in-class and best-in-class neuropsychiatric therapies.
Major companies operating in the neuroscience market are Alpha Omega Inc., General Electric Company, Siemens Healthineers AG, NeuroNexus Technologies Inc., Doric Lenses Inc., Blackrock Neurotech, Axion Biosystems Inc., Femtonics Ltd., Carl Zeiss AG, Danaher Corporation (Leica Microsystems), Koninklijke Philips N.V., Toshiba Corporation, Hitachi Medical Corporation, Scientifica Ltd., Intan Technologies Inc., Laserglow Technologies Inc., Mightex Systems, Neuralink Corporation, Kernel Corporation, BrainCo Inc., MindMaze Inc., Paradromics Inc., NeuroPro Inc., NeuroSky Inc., EMOTIV Inc., Cercare Medical A/S, Plexon Inc., Noldus Information Technology bv, Neuralynx Inc., Vigil Neuroscience.
North America was the largest region in the neuroscience market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroscience market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the neuroscience market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the neuroscience market by increasing the cost of importing advanced imaging components, electrophysiology equipment, and laboratory-grade optical systems essential for research and diagnostics. These cost pressures are most significant in regions dependent on imported scientific instruments, particularly Europe and Asia-Pacific, causing delays in the availability of neuro-microscopy, whole brain imaging systems, and electrophysiology devices. Segments such as research institutes, diagnostic labs, and hospitals face higher procurement expenses and extended installation timelines. Despite the challenges, tariffs are encouraging localized manufacturing, stimulating regional innovation, and supporting domestic suppliers of laboratory equipment.
The neuroscience market research report is one of a series of new reports that provides neuroscience market statistics, including neuroscience industry global market size, regional shares, competitors with a neuroscience market share, detailed neuroscience market segments, market trends and opportunities, and any further data you may need to thrive in the neuroscience industry. This neuroscience market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Neuroscience is the field that focuses on the study of the human brain and nervous system, utilizing cellular and molecular biology, anatomy and physiology, human behavior and cognition, and related disciplines to mechanistically map brain function. Neuroscience supports the development of drugs as well as treatment and prevention approaches for neurological conditions and also contributes to addressing a wide range of other health issues.
The primary types of neurosciences include neuro-microscopy, electrophysiology technologies, neuro-cellular manipulation, whole brain imaging, and others, which are delivered through instruments, consumables, and software and services. Neuro-microscopy refers to a specialized operating microscope designed for procedures involving the brain, spinal cord, and spine. It is used to illuminate and magnify deeper areas of the surgical field and features a binocular head with adjustable eyepieces and foot controls that enable unrestricted arm movement. Neuroscience applications are utilized by hospitals, diagnostic laboratories, and research and academic institutions.
The neuroscience market consists of the revenues earned by consulting services, installation services, and maintenance services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Neuroscience Market Characteristics
3. Neuroscience Market Supply Chain Analysis
4. Global Neuroscience Market Trends and Strategies
5. Neuroscience Market Analysis of End Use Industries
7. Global Neuroscience Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Neuroscience Total Addressable Market (TAM) Analysis for the Market
9. Neuroscience Market Segmentation
10. Neuroscience Market Regional and Country Analysis
11. Asia-Pacific Neuroscience Market
12. China Neuroscience Market
13. India Neuroscience Market
14. Japan Neuroscience Market
15. Australia Neuroscience Market
16. Indonesia Neuroscience Market
17. South Korea Neuroscience Market
18. Taiwan Neuroscience Market
19. South East Asia Neuroscience Market
20. Western Europe Neuroscience Market
21. UK Neuroscience Market
22. Germany Neuroscience Market
23. France Neuroscience Market
24. Italy Neuroscience Market
25. Spain Neuroscience Market
26. Eastern Europe Neuroscience Market
27. Russia Neuroscience Market
28. North America Neuroscience Market
29. USA Neuroscience Market
30. Canada Neuroscience Market
31. South America Neuroscience Market
32. Brazil Neuroscience Market
33. Middle East Neuroscience Market
34. Africa Neuroscience Market
36. Neuroscience Market Competitive Landscape and Company Profiles
37. Neuroscience Market Other Major and Innovative Companies
40. Neuroscience Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Neuroscience Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses neuroscience market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for neuroscience? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The neuroscience market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Neuro-Microscopy; Electrophysiology Technologies; Neuro-Cellular Manipulation; Whole Brain Imaging; Other Types2) By Service: Instruments And Consumables; Software And Services
3) By End User: Hospitals; Diagnostic Labs; Research And Academic Institutes
Subsegments:
1) By Neuro-Microscopy: Two-Photon Microscopy; Confocal Microscopy; Super-Resolution Microscopy2) By Electrophysiology Technologies: Patch Clamp Systems; Multi-Electrode Arrays (MEAs); Intracellular And Extracellular Recorders
3) By Neuro-Cellular Manipulation: Optogenetics Tools; Microinjection Systems; Electroporation Devices
4) By Whole Brain Imaging: Functional Magnetic Resonance Imaging (fMRI); Positron Emission Tomography (PET); Diffusion Tensor Imaging (DTI)
5) By Other Types: Neuroinformatics Tools; Brain-Computer Interface Technologies; Neuromodulation Devices
Companies Mentioned: Alpha Omega Inc.; General Electric Company; Siemens Healthineers AG; NeuroNexus Technologies Inc.; Doric Lenses Inc.; Blackrock Neurotech; Axion Biosystems Inc.; Femtonics Ltd.; Carl Zeiss AG; Danaher Corporation (Leica Microsystems); Koninklijke Philips N.V.; Toshiba Corporation; Hitachi Medical Corporation; Scientifica Ltd.; Intan Technologies Inc.; Laserglow Technologies Inc.; Mightex Systems; Neuralink Corporation; Kernel Corporation; BrainCo Inc.; MindMaze Inc.; Paradromics Inc.; NeuroPro Inc.; NeuroSky Inc.; EMOTIV Inc.; Cercare Medical A/S; Plexon Inc.; Noldus Information Technology bv; Neuralynx Inc.; Vigil Neuroscience
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Neuroscience market report include:- Alpha Omega Inc.
- General Electric Company
- Siemens Healthineers AG
- NeuroNexus Technologies Inc.
- Doric Lenses Inc.
- Blackrock Neurotech
- Axion Biosystems Inc.
- Femtonics Ltd.
- Carl Zeiss AG
- Danaher Corporation (Leica Microsystems)
- Koninklijke Philips N.V.
- Toshiba Corporation
- Hitachi Medical Corporation
- Scientifica Ltd.
- Intan Technologies Inc.
- Laserglow Technologies Inc.
- Mightex Systems
- Neuralink Corporation
- Kernel Corporation
- BrainCo Inc.
- MindMaze Inc.
- Paradromics Inc.
- NeuroPro Inc.
- NeuroSky Inc.
- EMOTIV Inc.
- Cercare Medical A/S
- Plexon Inc.
- Noldus Information Technology bv
- Neuralynx Inc.
- Vigil Neuroscience
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 40.35 Billion |
| Forecasted Market Value ( USD | $ 54.01 Billion |
| Compound Annual Growth Rate | 7.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
